EVerMed, Inc.
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$3.47M
Company Overview
EVerMed, Inc. is a Japanese biotechnology startup founded on April 15, 2024, as a spin-off from the Jikei University School of Medicine. The company focuses on developing novel treatments for intractable respiratory diseases by utilizing extracellular vesicles (EVs), based on the core research of its co-founder, Dr. Yu Fujita. EVerMed aims to create therapies that address the root causes of diseases, with a primary focus on the respiratory system and a secondary focus on advancing drug delivery systems (DDS). The company is venture-backed, having completed a seed funding round totaling approximately 510 million yen to accelerate its pipeline development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVerMed, Inc. Comps
Public and private peers based on sector, stage, and business model.
EVerMed, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 |
EVerMed, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WASEDA University Ventures | Seed |
EVerMed, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EVerMed, Inc.'s valuation, stock price, and market status.
